Stock Earnings

Question 1

What are Fennec Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Fennec Pharmaceuticals Inc has a total asset of $44, Net loss of $0

Question 2

What are the key financial ratios for FENC?

Accepted Answer

Fennec Pharmaceuticals Inc's Current ratio is 0.88, has a Net margin is 0, sales per share of $1.72.

Question 3

How is Fennec Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Fennec Pharmaceuticals Inc largest revenue segment is Sodium Thiosulfate, at a revenue of 21,641,736 in the most earnings release.For geography, United States is the primary market for Fennec Pharmaceuticals Inc, at a revenue of 21,641,736.

Question 4

Is Fennec Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Fennec Pharmaceuticals Inc has a net loss of $0

Question 5

Does Fennec Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Fennec Pharmaceuticals Inc has liability of 50

Question 6

How many outstanding shares for Fennec Pharmaceuticals Inc?

Accepted Answer

Fennec Pharmaceuticals Inc has a total outstanding shares of 27.52

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	38	47	21	1	0	0
Revenue Growth (YoY)	-22%	124%	2,000%	--	--	--
Cost of Revenue	2	3	1	0	--	--
Gross Profit	36	44	19	1	--	--
Selling, General & Admin	40	41	32	20	12	12
Research & Development	0	0	0	3	4	5
Operating Expenses	40	41	32	24	17	18
Other Non Operating Income (Expenses)	--	--	--	--	--	0
Pretax Income	-6	0	-16	-23	-17	-18
Income Tax Expense	--	0	--	--	--	--
Net Income	-6	0	-16	-23	-17	-18
Net Income Growth	--	-100%	-30%	35%	-6%	50%
Shares Outstanding (Diluted)	27.88	27.29	26.57	26.28	26.01	23.7
Shares Change (YoY)	3%	3%	1%	1%	10%	19%
EPS (Diluted)	-0.25	-0.01	-0.6	-0.9	-0.67	-0.76
EPS Growth	741%	-97%	-33%	34%	-12%	19%
Free Cash Flow	-7	26	-17	-18	-14	-15
Free Cash Flow Per Share	-0.25	0.95	-0.63	-0.68	-0.53	-0.63
Gross Margin	94.73%	93.61%	90.47%	100%	--	--
Operating Margin	-10.52%	4.25%	-57.14%	-2,200%	0%	0%
Profit Margin	-15.78%	0%	-76.19%	-2,300%	0%	0%
Free Cash Flow Margin	-18.42%	55.31%	-80.95%	-1,800%	0%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-4	2	-12	-22	-17	-17
EBIT Margin	-10.52%	4.25%	-57.14%	-2,200%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Fennec Pharmaceuticals Inc (FENC) Price

FENC Stock Price Chart

FENC Income

Follow-Up Questions